<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-1161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Артериальная гипертония и ишемическая болезнь сердца в реальной практике врача-кардиолога</article-title><trans-title-group xml:lang="en"><trans-title>Arterial hypertension and coronary heart disease in real-world cardiology practice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шальнова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shalnova</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">oganov@online.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Деев</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Deev</surname><given-names>A. D.</given-names></name></name-alternatives><email xlink:type="simple">oganov@online.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпов</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpov</surname><given-names>Yu. A.</given-names></name></name-alternatives><email xlink:type="simple">oganov@online.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственный научно-исследовательский центр профилактической медицины Росздрава</institution></aff><aff xml:lang="en"><institution>State Research Center for Preventive Medicine, Russian Federal Agency of Health and Social Development</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НИИ клинической кардиологии им. А.Л.Мясникова РК НПК Росздрава. Москва</institution></aff><aff xml:lang="en"><institution>A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, Russian Federal Agency of Health and Social Development. Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>20</day><month>04</month><year>2006</year></pub-date><volume>5</volume><issue>2</issue><fpage>73</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шальнова С.А., Деев А.Д., Карпов Ю.А., 2006</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="ru">Шальнова С.А., Деев А.Д., Карпов Ю.А.</copyright-holder><copyright-holder xml:lang="en">Shalnova S.A., Deev A.D., Karpov Y.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/1161">https://cardiovascular.elpub.ru/jour/article/view/1161</self-uri><abstract><p>Цель. Изучить взаимоотношения артериальной гипертонии (АГ) и ишемической болезни сердца (ИБС) в реальной клинической практике врача-кардиолога. Для этого было проведено национальное исследование ПРЕМЬЕРА. Материал и методы. В исследовании приняли участие 199 врачей-кардиологов из 14 городов Российской Федерации. Каждый врач в течение 5 дней последовательно включал в исследование больных обоего пола в возрасте 18-65 лет, страдающих АГ и/или ИБС. На эпидемиологическом этапе в исследование были включены 14075 пациентов. Случайным образом отобраны для анализа 8578 пациентов, из них с АГ – 8257, в т.ч. 3615 (42,1%) мужчин и 4963 (57,9%) женщин. У больных определялись социально-демографические характеристики; регистрировались жалобы, основные факторы риска (ФР), предшествующая терапия, регулярность приема и причины нерегулярного применения лекарственных препаратов. Каждому больному измеряли артериальное давление и частоту сердечных сокращений, анализировали электрокардиограмму покоя. Результаты. Различные формы ИБС, включая инфаркт миокарда, стенокардию напряжения, безболевую ИБС, аритмии, отмечались у 74,2% мужчин и 61,2% женщин, больных АГ. При анализе ФР, ассоциирующихся с АГ и ИБС, оказалось, что 88,5% больных АГ и 95,6% больных АГ и ИБС имели хотя бы один ФР. Образование является весьма существенной детерминантой здоровья населения России, определяя его информированность, поведенческие ФР и как следствие – заболеваемость и отношение к лечению. Лица с высшим образованием чаще имеют отягощенный семейный анамнез по ССЗ, нарушения липидного обмена и подвержены хроническому стрессу. Напротив, больные с образованием ниже среднего достоверно чаще курят, злоупотребляют алкоголем; они более отягощены симптомами ССЗ. Заключение. Таким образом, результаты исследования ПРЕМЬЕРА позволяют достоверно оценить практику врача-кардиолога, охарактеризовать больных изолированной АГ и в сочетании с ИБС, начиная с жалоб и заканчивая оценкой приверженности лечению, в т.ч. в зависимости от социального статуса.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To study association of arterial hypertension (AH) and coronary heart disease (CHD) in real-world cardiology practice. This was the aim of the national PREMIERE Study. Material and methods. The study involved cardiologists from 14 cities of the Russian Federation. During 5 days, every doctor included all consecutive AH and/or CHD male and female patients, aged 18-65 years. During epidemiology phase, 14 075 patients were recruited in the study. For the analysis, 8578 patients were randomly selected, including 3615 (42.1%) males and 4963 (57.9%) females. In all participants, socio-demographic characteristics were measured; complaints, main risk factors (RF), already prescribed therapy, intake regularity and causes of irregular medication intake were registered. Blood pressure and heart rate were measured; electrocardiogram at rest was analyzed. Results. Various CHD forms, including myocardial infarction, effort angina, painless CHD, cardiac arrhythmias, were observed in 72.4% of AH males and 61.2% of AH females. Analyzing RF, associated with AH and CHD, it turned out that 88.5% of AH patients and 95.6% of AH and CHD patients had at least one RF. Education level was a significant determinant for Russian population health, defining awareness, behavioral RF and, therefore, morbidity and treatment attitudes. Persons with higher education more often had cardiovascular disease in family history, lipid profile disturbances, and chronic stress exposure. On the contrary, patients with lower than secondary education level significantly more often smoked, drank alcohol, and had cardiovascular symptoms. Conclusion. Therefore, REMIERE Study results give a chance to assess present cardiology practice, to characterize patients with isolated AH or AH combined with CHD, including complaints and treatment compliance, according to social status and other parameters.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертония</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>факторы риска</kwd><kwd>врач-кардиолог</kwd><kwd>исследование «ПРЕМЬЕРА»</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Arterial hypertension</kwd><kwd>coronary heart disease</kwd><kwd>risk factors</kwd><kwd>cardiologist</kwd><kwd>PREMIERE Study</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Murray C, Lopez A. The Global Burden of Disease. Cambridge: Harvard University Press, 1996.</mixed-citation><mixed-citation xml:lang="en">Murray C, Lopez A. The Global Burden of Disease. Cambridge: Harvard University Press, 1996.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Оганов Р.Г. Проблема контроля артериальной гипертонии среди населения. Кардиология 1994; 3: 80-3.</mixed-citation><mixed-citation xml:lang="en">Оганов Р.Г. Проблема контроля артериальной гипертонии среди населения. Кардиология 1994; 3: 80-3.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Распространенность артериальной гипертонии в России: информированность, лечение, контроль. Профил забол укреп здор 2001; 2: 3-7.</mixed-citation><mixed-citation xml:lang="en">Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Распространенность артериальной гипертонии в России: информированность, лечение, контроль. Профил забол укреп здор 2001; 2: 3-7.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова С.А., Деев А.Д., Шестов Д.Б., и др. Прогностическая оценка эпидемиологических характеристик ишемической болезни сердца. Кардиология 1997; 9: 49-54.</mixed-citation><mixed-citation xml:lang="en">Шальнова С.А., Деев А.Д., Шестов Д.Б., и др. Прогностическая оценка эпидемиологических характеристик ишемической болезни сердца. Кардиология 1997; 9: 49-54.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Swales J. Textbook of hypertension. Oxford: Blackwell Scientific; 1994.</mixed-citation><mixed-citation xml:lang="en">Swales J. Textbook of hypertension. Oxford: Blackwell Scientific; 1994.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Leppala JM, Virtamo J, Fogelholm R, et al. Different risk factors for different stroke subtype: association of blood pressure, cholesterol and antoxidants. Stroke 1999; 30: 2634-40.</mixed-citation><mixed-citation xml:lang="en">Leppala JM, Virtamo J, Fogelholm R, et al. Different risk factors for different stroke subtype: association of blood pressure, cholesterol and antoxidants. Stroke 1999; 30: 2634-40.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risks: of fatal coronary heart disease. Hypertension 1989; 13 (Suppl.): I2-12.</mixed-citation><mixed-citation xml:lang="en">Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risks: of fatal coronary heart disease. Hypertension 1989; 13 (Suppl.): I2-12.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Part 1. Prolong differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.</mixed-citation><mixed-citation xml:lang="en">MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Part 1. Prolong differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Asia Pacific cohort studies collaboration. Cardiovascular disease in Asia Pacific region. J Hypertens 2002; in press.</mixed-citation><mixed-citation xml:lang="en">Asia Pacific cohort studies collaboration. Cardiovascular disease in Asia Pacific region. J Hypertens 2002; in press.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lawes C, Bennet D, Lewington S, Rodgers A. Blood pressure and coronary heart disease: a review of evidence. Semin in vasc med 2002; 2(4): 355-68.</mixed-citation><mixed-citation xml:lang="en">Lawes C, Bennet D, Lewington S, Rodgers A. Blood pressure and coronary heart disease: a review of evidence. Semin in vasc med 2002; 2(4): 355-68.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Keil JE, Southerland SE, Knapp RG, et al. Mortality rates and risk factors for coronary heart disease in black as compared with white men and women. New Engl J Med 1993; 329: 73-8.</mixed-citation><mixed-citation xml:lang="en">Keil JE, Southerland SE, Knapp RG, et al. Mortality rates and risk factors for coronary heart disease in black as compared with white men and women. New Engl J Med 1993; 329: 73-8.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Keil JE, Southerland SE, Hames CG, et al. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC and Evans County, Georgia, heart studies. Arch Intern Med 1995; 155: 1521-7.</mixed-citation><mixed-citation xml:lang="en">Keil JE, Southerland SE, Hames CG, et al. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC and Evans County, Georgia, heart studies. Arch Intern Med 1995; 155: 1521-7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med 1992; 152: 56-64.</mixed-citation><mixed-citation xml:lang="en">Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med 1992; 152: 56-64.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lawes C, Bennet D, Lewington S, Rodgers A. Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med 2002; 2(4): 355-68.</mixed-citation><mixed-citation xml:lang="en">Lawes C, Bennet D, Lewington S, Rodgers A. Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med 2002; 2(4): 355-68.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">SAS/STAT User’s Guide, Version 6, Fourth Edition, Vol.1 &amp; 2, SAS Institute Inc., Cary, NC, USA, 1990.</mixed-citation><mixed-citation xml:lang="en">SAS/STAT User’s Guide, Version 6, Fourth Edition, Vol.1 &amp; 2, SAS Institute Inc., Cary, NC, USA, 1990.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dahlof B, Sever P, Poulter N, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes TrialBlood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. www.thelancet.com Published online September 4, 2005.</mixed-citation><mixed-citation xml:lang="en">Dahlof B, Sever P, Poulter N, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes TrialBlood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. www.thelancet.com Published online September 4, 2005.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemilogical context. Lancet 1990; 335: 827-38.</mixed-citation><mixed-citation xml:lang="en">Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemilogical context. Lancet 1990; 335: 827-38.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Verdecchia P, ReboldiG, Angelli F, et al. Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension 2005; 46(2): 386-92.</mixed-citation><mixed-citation xml:lang="en">Verdecchia P, ReboldiG, Angelli F, et al. Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension 2005; 46(2): 386-92.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. JACC 1993; 22 (4Suppl A): 6A-13.</mixed-citation><mixed-citation xml:lang="en">Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. JACC 1993; 22 (4Suppl A): 6A-13.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т., Даниэлян М.О. Первые результаты национального обследования больных ХСН в реальной практике (по обращаемости) – ЭПОХА-ОХСН. Серд недостат 2003; 4(3): 116-21.</mixed-citation><mixed-citation xml:lang="en">Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т., Даниэлян М.О. Первые результаты национального обследования больных ХСН в реальной практике (по обращаемости) – ЭПОХА-ОХСН. Серд недостат 2003; 4(3): 116-21.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
